VolitionRx Ltd Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Intangible Assets (Tables)

Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2017

Patents amortized over their remaining lives

The Company’s intangible assets consist of intellectual property and patents, mainly acquired in the acquisition of Belgian Volition (formerly ValiBio SA). The patents and intellectual property are being amortized over the assets’ estimated useful lives, which range from 8 to 20 years.

					March 31,
					2017
			Accumulated		Net Carrying
	Cost		Amortization		Value
	$		$		$

Patents		1,099,667		510,866		588,801

		1,099,667		510,866		588,801

					December 31,
					2016
			Accumulated		Net Carrying
	Cost		Amortization		Value
	$		$		$

Patents		1,085,133		482,940		602,193

		1,085,133		482,940		602,193

Annual estimated amortization schedule

The Company amortizes the long-lived assets on a straight line basis with terms ranging from 8 to 20 years. The annual estimated amortization schedule over the next five years is as follows:

2017 - remaining	$	62,948
2018	$	83,868
2019	$	83,868
2020	$	83,868
2021	$	83,868